Anticipate Changes to ICH E6 GCP that Effect Clinical Trial Records

Hello E,

Fierce Pharma and Fierce Biotech are pleased to welcome Andy Fisher, Senior Inspector from the Medicines and Healthcare products Regulatory Agency (MHRA), as a keynote speaker at the Fierce European TMF Summit! Learn what to expect, this 14-16 November in London, in terms of changes to ICH E6 GCP that may affect clinical trial records.

As a subscriber of Fierce Biotech, please enjoy a 15% discount on your registration. Register now and use promo code FB15 to save. This offer is only valid for new registrations.

Keynote Spotlight

Changes to ICH E6 GCP that Directly Effect Clinical Trial Records

Andy Fisher, MS

Lead Senior Inspector

Medicines and Healthcare products Regulatory Agency (MHRA)

The Fierce European TMF Summit is the cornerstone event in clinical document management. It offers attendees opportunities for education, collaboration, and networking, creating a plethora of resources for the industry and this year’s Summit will expand upon the Summit’s decade-long legacy.

I hope to see you in November!

Best Regards,

Aimee Gutzler
Sr. Conference Production Director | Fierce Life Sciences

Book Your Room Today!

Special attendee discount ends 24 Oct.

Hyatt Regency Churchill

30 Portman Square
London W1H 7BH, UK

Contact us with questions:

For speaking opportunities, contact Aimee Gutzler at [email protected].

For group rates, contact Richard Watanabe at [email protected].

For partnership opportunities, complete this form here.

Thank You to Our 2022 Partners

STRATEGIC PARTNERS

PLATINUM

GOLD

SILVER

SUPPORTERS

If you no longer wish to receive promotion on this event, simply unsubscribe.
Refer to our Privacy Policy.
Fierce Life Sciences is a division of Questex LLC.
685 3rd Ave 21st Floor New York, NY 10017

Contact Us
© 2022 Questex LLC. All Rights Reserved.
Reproduction in whole or in part is prohibited without written permission.